Stay updated on Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Sign up to get notified when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.

Latest updates to the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.4%
- Check57 days agoChange DetectedDifference0.4%
Stay in the know with updates to Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.